Related Experiment Videos

Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen

F Ferraraccio1, M Accardo, F Giangaspero

  • 1Department of Morphopathology, II University, Naples, Italy.

Clinical Neuropathology
|August 12, 2003
PubMed
Abstract

Insights

Histological analysis of meningiomas is limited. Cell proliferation markers like Ki67 labeling index (LI), DNA ploidy, and AgNOR aid in grading meningiomas, improving diagnostic accuracy beyond standard histopathology.

Area of Science:

  • Neuro-oncology
  • Pathology
  • Molecular Biology

Background:

  • Standard histological analysis of meningiomas has limitations in predicting biological behavior.
  • Accurate grading of meningiomas is crucial for determining prognosis and treatment strategies.

Purpose of the Study:

  • To investigate the utility of cell proliferation indicators in evaluating histologically benign meningiomas.
  • To assess the predictive value of Ki67 labeling index (LI), DNA ploidy, and AgNOR in meningioma grading.

Main Methods:

  • Studied 50 meningothelial meningiomas, 50 atypical meningiomas, and 8 primary benign meningiomas with recurrences.
  • Evaluated Ki67 LI, DNA ploidy, and AgNOR using a computerized image analyzer.
  • Quantitatively processed and assessed results for each case.

Main Results:

  • Ki67 LI was significantly higher in atypical (26.6%) and recurrent (28%) meningiomas compared to typical (11.3%) and primary (13.6%) meningiomas.
  • AgNOR granule counts were higher in atypical (1.98) and recurrent (1.92) meningiomas than in typical (1.51) and primary (1.49) meningiomas.
  • DNA ploidy analysis revealed increased hyperploid nuclei in atypical (24.63%) and recurrent (17.98%) meningiomas compared to primary (7.02%) meningiomas.

Conclusions:

  • Ki67 LI, DNA ploidy, and AgNOR are valuable indicators of cell proliferation in meningiomas.
  • Integrating these proliferation markers with standard histopathology improves the accuracy of meningioma grading.
  • These markers offer better prognostic information for meningioma patients.

Related Concept Videos